Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance.
about
OCT4 Expression Enhances Features of Cancer Stem Cells in a Mouse Model of Breast CancerTargeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressivenessCancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinomaCancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectivesThe biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized careThe cancer stem cell niche--there goes the neighborhood?Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcomaPinellia pedatisecta agglutinin targets drug resistant K562/ADR leukemia cells through binding with sarcolemmal membrane associated protein and enhancing macrophage phagocytosisIn situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.Autophagy regulates the stemness of cervical cancer stem cells.Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.Synthetic, non-saccharide, glycosaminoglycan mimetics selectively target colon cancer stem cells.Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugsExpressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma.TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.Ectopic expression of the WWOX gene suppresses stemness of human ovarian cancer stem cells.Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus.Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cellsInhibitor of DNA-binding 4 contributes to the maintenance and expansion of cancer stem cells in 4T1 mouse mammary cancer cell line.Effect of the WWOX gene on the regulation of the cell cycle and apoptosis in human ovarian cancer stem cells.Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis.Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancersEnhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells.Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo.Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells.Cancer stem cell theory: therapeutic implications for nanomedicine.Synthesis and characterization of DNA minor groove binding alkylating agentsInhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenanceBeclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cellsOvercoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling.Advances in the proteomic discovery of novel therapeutic targets in cancer.Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cellsThe functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals.Do stem-like cells play a role in drug resistance of sarcomas?A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells.Cancer stem cells in osteosarcoma: recent progress and perspective.Antigens in chronic myeloid leukemia: implications for vaccine development.Hypomethylation of repeated DNA sequences in cancer.
P2860
Q24627533-A4C178EE-71FE-453D-AB4A-C61C75AFDD6CQ26822776-505E33BD-648D-4AEA-A726-9B8B45E869F5Q26998068-9695D0FE-C308-4D0B-A541-E7B1829B5088Q27024651-2D6DEBE1-2376-4AE2-9E87-F6660A7E4D17Q28066460-E5AC0C1E-0D1B-4343-B768-8A8E6B2A78BBQ28244178-BF25A0C5-1F88-4958-8B48-F91C16D95F3FQ28482489-42F16DBA-3BC7-4DFE-9922-2CB1616F5983Q28536615-0B63F653-2B88-4D57-AD72-CFE79B615440Q33816271-0402DDC9-A950-45CE-8193-D4BFA6B5822BQ33834806-FF3BEEBB-E718-41D4-BE9D-A394DE2ED69AQ34043017-D5B2C4E2-7AF4-40F5-A8CA-53D8BA0E2DECQ34061158-6374F07F-E013-48CF-AE1F-B48F942C0AC5Q34123603-D78AB1B5-E8C1-426F-BD78-7A81EC75610AQ34331551-698E5E26-05F7-4B22-823C-F384F925B792Q35085542-4E1987F1-B0C9-42E6-83DE-28CCF4A068EEQ35167819-6CE2DAE6-28F6-413A-AD15-E331CBF6C3ABQ35571898-CCE909FA-622E-4F57-8EBE-DE2465D8BB97Q35601012-B4E56209-EB4E-4A14-877D-92390F7B197AQ35653415-C3F55DC6-7102-4E41-B9D5-F316C6DBC5F9Q35727976-D4AA4A18-AFAC-473A-BDE1-55B2106EA668Q35833372-7C03EE78-8B82-4DB1-8753-3F32FA7D7C85Q35852989-64F1AE05-18D3-47E6-90AD-1121963BAC9CQ35918956-E60891BA-BC2D-42D6-9070-5F3FCF29B22FQ36021018-35CC37AF-A655-4B3D-8CE6-2700F8B32BCDQ36104984-A0753F42-C7AC-4BF3-89FA-F596D789958EQ36237528-CB28EF86-24D5-48CC-875C-BCB94D0E7DD4Q36659443-33E96D53-52DB-4ADC-B3FD-EEA6BE51FC5FQ36746192-A28C5DA8-1271-4FC0-ADAE-B78CC5F95DBFQ36892078-024129B2-3771-4016-88FC-C00047DC3A15Q36920654-7857303A-FCDA-4A0E-96E3-06F7F577A3C5Q36998357-CB38224E-9BDE-4CB7-85B6-7D4DD8BDE02AQ37260569-FB696509-7F3A-4DB3-9C3E-49AEE3E13B1EQ37437614-25482EF8-0438-4F65-B1F7-A946ED57325BQ37664869-9B34C0B7-DE46-4866-82AF-B9CD15D14546Q37687392-A1BC668A-055F-4C1E-8AFA-0E41F6BA8CC8Q37694661-51E085A3-F3FE-4217-9A82-E779B6C17D0BQ37715171-7F2B7C42-293C-4C2B-A8A9-EBD32530AD15Q37896083-A2410E29-B148-4CE6-A557-3F2CEE19B69FQ37950233-91D34560-2678-435F-98AB-EE1600932837Q37961724-959A32F9-223B-452E-AFC7-9763F7723553
P2860
Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer stem cells: a new parad ...... ogression and drug resistance.
@en
Cancer stem cells: a new parad ...... ogression and drug resistance.
@nl
type
label
Cancer stem cells: a new parad ...... ogression and drug resistance.
@en
Cancer stem cells: a new parad ...... ogression and drug resistance.
@nl
prefLabel
Cancer stem cells: a new parad ...... ogression and drug resistance.
@en
Cancer stem cells: a new parad ...... ogression and drug resistance.
@nl
P2093
P1476
Cancer stem cells: a new parad ...... ogression and drug resistance.
@en
P2093
Alfredo Cesario
Anna Maria Orengo
Laura Paleari
Leonardo Chessa
Patrizia Russo
Rosaria Gangemi
Silvano Ferrini
P304
P356
10.2174/092986709788186147
P577
2009-01-01T00:00:00Z